Detection and measurement of microparticles: An evolving research tool for vascular biology

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 8, 2007, Pages 771-779

  Enjeti, Anoop K ^a   Lincz, Lisa F ^a   Seldon, Michael ^a  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

Author keywords

Detection; Measurement; Microparticles; Research tool; Vascular biology

Indexed keywords

FIBRINOGEN RECEPTOR; PHOSPHATIDYLSERINE;

APOPTOSIS; ASSAY; BIO MALEIMIDE STAIN; BIOLOGY; CARDIOVASCULAR SYSTEM; CELL ACTIVATION; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CELL STIMULATION; CLASSIFICATION; CLOT BASED ASSAY; CYTOLOGY; DILUTE ACTIVATED PARTIAL THROMBOPLASTIN TIME; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; MEASUREMENT; MEMBRANE MICROPARTICLE; MICROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROCESSING; RESEARCH; REVIEW; STANDARDIZATION; TECHNIQUE; THROMBOSIS; X ACTIVATED CLOTTING TIME;

BLOOD CELLS; BLOOD VESSELS; CELL MEMBRANE; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MICROSCOPY; PARTICLE SIZE;

EID: 38549176742     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1000369     Document Type: Review

References (68)

1. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003;1:1655-1662
2. Ahn YS. Cell-derived microparticles: 'miniature envoys with many faces.' J Thromb Haemost 2005;3:884-887
3. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion 2006;46:143-152
4. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992;119:334-345
5. Stern RC, Liu K, Dodge RK, Elenitoba-Johnson KS, Layfield LJ. Significance of lymphoglandular bodies in bone marrow aspiration smears. Diagn Cytopathol 2001;24:240-243
6. Francis IM, Das DK, al-Rubah NA, Gupta SK. Lymphoglandular bodies in lymphoid lesions and non-lymphoid round cell tumours: a quantitative assessment. Diagn Cytopathol 1994;11:23-27
7. Papadimitriou JC, Drachenberg CB, Brenner DS, et al. " Thanatosomes": a unifying morphogenetic concept for tumor hyaline globules related to apoptosis. Hum Pathol 2000;31:1455-1465
8. Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS. New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 2004;53:210-230
9. Kereiakes DJ, Michelson AD. Platelet activation and progression to complications. Rev Cardiovasc Med 2006;7: 75-81
10. Sturk-Maquelin KN, Nieuwland R, Romijn FP, et al. Proand non-coagulant forms of non-cell-bound tissue factor in vivo. J Thromb Haemost 2003;1:1920-1926
11. Steppich B, Mattisek C, Sobczyk D, et al. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005;93:35-39
12. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171-178
13. Exner T, Joseph JE, Connor D, Low J, Ma DD. Increased procoagulant phospholipid activity in blood from patients with suspected acute coronary syndromes: a pilot study. Blood Coagul Fibrinolysis 2005;16:375-379
14. Vidal C, Spaulding C, Picard F, et al. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb Haemost 2001;86:784-790
15. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118-1135
16. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102
17. Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995;21:217-231; discussion 231a
18. Warkentin TE, Sheppard JI. Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists. Platelets 1999;10:319-326
19. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 2006;36:104-107
20. Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000;7:273-277
21. Raybagkar DA, Patchipulusu S, Mast AE, Hall CL. In vitro flow evaluation of recombinant tissue factor pathway inhibitor immobilized on collagen impregnated Dacron. ASAIO J 2004;50:301-305
22. Biro E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003;1:2561-2568
23. Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003;9:458-462
24. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005;288:H1004-H1009
25. Mallat Z, Hugel B, Ohan J, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999;99:348-353
26. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 2006;27:817-823
27. Tedgui A, Mallat Z. Apoptosis as a determinant of atherothrombosis. Thromb Haemost 2001;86:420-426
28. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 2005;66:1146-1154
29. Gross PL, Furie BC, Merrill-Skoloff G, Chou J, Furie B. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol 2005;78:1318-1326
30. Satta N, Toti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994;153: 3245-3255
31. Villmow T, Kemkes-Matthes B, Matzdorff AC. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Res 2002;108:139-145
32. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007;66:159-165
33. White JG, Hagert K, Nipper JH, Rao GH. Functional platelets after storage in vitro for 15-21 days. Am J Pathol 1980;101:613-634
34. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-1721
35. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006;134:307-313
36. Simmons E, MaGuire C, Lichti E, Helvey W, Almond C. A comparison of the microparticles produced when two disposable-bag oxygenators and a disc oxygenator are used for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1972;63:613-621
37. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102:2678-2683
38. Prasad KS, Andre P, He M, et al. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci USA 2003;100:12367-12371
39. Cachet C, Ennamany R, Kretz O, et al. Bolesatine induces agglutination of rat platelets and human erythrocytes and platelets in vitro. Hum Exp Toxicol 1996;15:26-29
40. Faye RS, Aamdal S, Hoifodt HK, et al. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients. Clin Cancer Res 2004; 10:4134-4139
41. Bruland OS, Hoifodt H, Saeter G, Smeland S, Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 2005;11:4666-4673
42. Fondu P. Heparin-associated thrombocytopenia: an update. Acta Clin Belg 1995;50:343-357
43. Keng TB, Chong BH. Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin. Br J Haematol 2001;114:394-396
44. Nomura S, Yanabu M, Kido H, et al. Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura. Ann Hematol 1991;62:103-107
45. Dachary-Prigent J, Toti F, Satta N, et al. Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost 1996;22:157-164
46. Lopez MS, Mecerreyes D, Lopez-Cabarcos E, Lopez-Ruiz B. Amperometric glucose biosensor based on polymerized ionic liquid microparticles. Biosens Bioelectron 2006;21:2320-2328
47. Leach JK, O'Rear EA, Patterson E, Miao Y, Johnson AE. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. Thromb Haemost 2003;90:64-70
48. Jiao YY, Ubrich N, Hoffart V, et al. Preparation and characterization of heparin-loaded polymeric microparticles. Drug Dev Ind Pharm 2002;28:1033-1041
49. Rodriguez M, Antunez JA, Taboada C, Seijo B, Torres D. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J Pharm Pharmacol 2001;53:1207-1215
50. Tamilvanan S, Sa B. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of Ibuprofen. AAPS PharmSciTech 2006;7:72
51. Vordermeier HM, Coombes AG, Jenkins P, et al. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 1995;13:1576-1582
52. Dignat-George F, Camoin-Jau L, Sabatier F, et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 2004;91:667-673
53. Freyssinet JM, Dignat-George F. More on: measuring circulating cell-derived microparticles. J Thromb Haemost 2005;3:613-614
54. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001;112:81-90
55. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001;74:397-404
56. Enjeti AK, Lisa L, Seldon M. BioMaleimide as a generic stain for detection and quantitation of microparticles. Int J Lab Haematol 2007 July; [epub ahead of print]
57. Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemost 2005;3:2081-2088
58. Hughes M, Hayward CP, Warkentin TE, et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000;96:188-194
59. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004;2:1842-1851
60. Exner T, Joseph J, Low J, Connor D, Ma D. A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis 2003;14:773-779
61. Combes V, Dignat-George F, Mutin M, Sampol J. A new flow cytometry method of platelet-derived microvesicle quantitation in plasma. Thromb Haemost 1997;77:220
62. Enjeti AK, Lisa L, Seldon M. Preanalytical variables in the flow cytometric analysis of microparticles. J Thromb Haemost 2007;5(Suppl 2):P-S-522
63. Kim HK, Song KS, Lee ES, et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinolysis 2002;13:393-397
64. Robert S, Poncelet P, Camoin L, Dignat-Georges F. Standardization of microparticle counting using flow cytometry: new options and tools for the control of critical instrument settings. J Thromb Haemost 2007;5(Suppl 2): P-M-442
65. Furie B, Furie BC. Cancer-associated thrombosis. Blood Cells Mol Dis 2006;36:177-181
66. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004;11:156-164
67. Stevens PW, Kelso DM. Imaging and analysis of immobilized particle arrays. Anal Chem 2003;75:1147-1154
68. Banfi C, Brioschi M, Wait R, et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005;5:4443-4455